Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |